PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Magnetic Resonance Center (CERM), University of Florence, Sesto Fiorentino, Florence, Italy.\', \'Giotto Biotech srl, Sesto Fiorentino, Florence, Italy.\', \'Consorzio Interuniversitario Risonanze Magnetiche di Metallo Proteine (CIRMMP), University of Florence, Sesto Fiorentino, Florence, Italy.\', \'Department of Clinical and Experimental Medicine, University of Florence, Florence, Italy.\', \'Department of Chemistry \'Ugo Schiff\', University of Florence, Sesto Fiorentino, Florence, Italy.\', \'Cardiac Anaesthesia and Intensive Care Unit, Careggi University Hospital, Florence, Italy.\', \'Pneumology and Intensive Care Unit, Careggi University Hospital, Florence, Italy.\', \'Intensive Care Unit and Regional ECMO Referral Centre, Careggi University Hospital, Florence, Italy.\', \'Infectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy.\', \'Immunology and Cell Therapy Unit, Careggi University Hospital, Florence, Italy.\', \'Flow Cytometry Diagnostic Center and Immunoterapy (CDCI), Careggi University Hospital, Florence, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1371/journal.ppat.1009243
?:doi
?:hasPublicationType
?:journal
  • PLoS pathogens
is ?:pmid of
?:pmid
?:pmid
  • 33524041
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 4.006
?:rankingScore_hIndex
  • 154
?:title
  • Metabolomic/lipidomic profiling of COVID-19 and individual response to tocilizumab.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all